Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	Hepatology 2012 (546 pages, free PDF) Hepatitis C 2012 (150 pages, free PDF)	Free Medical Books

Chronic Heart Failure

Free Subscription Articles published in Am Heart J Retrieve available abstracts of 119 articles: HTML format Text format

Single Articles

March 2012
1. HSICH EM , Grau-Sepulveda MV, Hernandez AF, Peterson ED, et al
   Sex differences in in-hospital mortality in acute decompensated heart failure with reduced and preserved ejection fraction.
   Am Heart J. 2012;163:430-437.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. PERIN EC , Silva GV, Zheng Y, Gahremanpour A, et al
   Randomized, double-blind pilot study of transendocardial injection of autologous aldehyde dehydrogenase-bright stem cells in patients with ischemic heart failure.
   Am Heart J. 2012;163:415-421.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. MAEDER MT , Rickli H, Pfisterer ME, Muzzarelli S, et al
   Incidence, clinical predictors, and prognostic impact of worsening renal function in elderly patients with chronic heart failure on intensive medical therapy.
   Am Heart J. 2012;163:407-414.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   February 2012
4. DUBIN R , Li Y, Ix JH, Shlipak MG, et al
   Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: Data from the Heart and Soul Study.
   Am Heart J. 2012;163:274-9.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. BOOM NK , Lee DS, Tu JV
   Comparison of processes of care and clinical outcomes for patients newly hospitalized for heart failure attended by different physician specialists.
   Am Heart J. 2012;163:252-9.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. HOEKSTRA T , Jaarsma T, Sanderman R, van Veldhuisen DJ, et al
   Perceived sexual difficulties and associated factors in patients with heart failure.
   Am Heart J. 2012;163:246-51.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. HEIDENREICH PA , Zhao X, Hernandez AF, Yancy CW, et al
   Patient and hospital characteristics associated with traditional measures of inpatient quality of care for patients with heart failure.
   Am Heart J. 2012;163:239-245.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. PONIKOWSKI P , Metra M, Teerlink JR, Unemori E, et al
   Design of the RELAXin in Acute Heart Failure Study.
   Am Heart J. 2012;163:149-155.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. SIPAHI I , Chou JC, Hyden M, Rowland DY, et al
   Effect of QRS morphology on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials.
   Am Heart J. 2012;163:260-7.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   January 2012
10. FLYNN KE , Lin L, Moe GW, Howlett JG, et al
    Relationships between changes in patient-reported health status and functional capacity in outpatients with heart failure.
    Am Heart J. 2012;163:88-94.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. WILCOX JE , Fonarow GC, Yancy CW, Albert NM, et al
    Factors associated with improvement in ejection fraction in clinical practice among patients with heart failure: Findings from IMPROVE HF.
    Am Heart J. 2012;163:49-56.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2011
12. POSTMUS D , Abdul Pari AA, Jaarsma T, Luttik ML, et al
    A trial-based economic evaluation of 2 nurse-led disease management programs in heart failure.
    Am Heart J. 2011;162:1096-104.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. MEDEIROS A , Biagi DG, Sobreira TJ, de Oliveira PS, et al
    Mutations in the human phospholamban gene in patients with heart failure.
    Am Heart J. 2011;162:1088-1095.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. WHELLAN DJ , Nigam A, Arnold M, Starr AZ, et al
    Benefit of exercise therapy for systolic heart failure in relation to disease severity and etiology-findings from the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training study.
    Am Heart J. 2011;162:1003-10.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. DESAI AS , Lewis EF, Li R, Solomon SD, et al
    Rationale and design of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial: A randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction.
    Am Heart J. 2011;162:966-972.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
16. CASTAGNO D , Baird-Gunning J, Jhund PS, Biondi-Zoccai G, et al
    Intensive glycemic control has no impact on the risk of heart failure in type 2 diabetic patients: Evidence from a 37,229 patient meta-analysis.
    Am Heart J. 2011;162:938-948.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. ARITI CA , Cleland JG, Pocock SJ, Pfeffer MA, et al
    Days alive and out of hospital and the patient journey in patients with heart failure: Insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program.
    Am Heart J. 2011;162:900-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. AGUILAR D
    Heart failure and diabetes: Time to pay attention.
    Am Heart J. 2011;162:795-7.
    PubMed     Text format     Related articles   
    
    
    
    October 2011
19. SHAH AM , Hung CL, Shin SH, Skali H, et al
    Cardiac structure and function, remodeling, and clinical outcomes among patients with diabetes after myocardial infarction complicated by left ventricular systolic dysfunction, heart failure, or both.
    Am Heart J. 2011;162:685-91.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. KELLY DJ , Gershlick T, Witzenbichler B, Guagliumi G, et al
    Incidence and predictors of heart failure following percutaneous coronary intervention in ST-segment elevation myocardial infarction: The HORIZONS-AMI trial.
    Am Heart J. 2011;162:663-70.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. POVSIC TJ , O'Connor CM, Henry T, Taussig A, et al
    A double-blind, randomized, controlled, multicenter study to assess the safety and cardiovascular effects of skeletal myoblast implantation by catheter delivery in patients with chronic heart failure after myocardial infarction.
    Am Heart J. 2011;162:654-662.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. KAWAHARA C , Tsutamoto T, Sakai H, Nishiyama K, et al
    Prognostic value of serial measurements of highly sensitive cardiac troponin I in stable outpatients with nonischemic chronic heart failure.
    Am Heart J. 2011;162:639-45.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
23. SZYMANSKI MK , Damman K, van Veldhuisen DJ, van Gilst WH, et al
    Prognostic value of renin and prorenin in heart failure patients with decreased kidney function.
    Am Heart J. 2011;162:487-93.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. KAPOOR JR , Fonarow GC, Zhao X, Kapoor R, et al
    Diabetes, quality of care, and in-hospital outcomes in patients hospitalized with heart failure.
    Am Heart J. 2011;162:480-486.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. ALMOND CS , Buchholz H, Massicotte P, Ichord R, et al
    Berlin Heart EXCOR Pediatric ventricular assist device Investigational Device Exemption study: study design and rationale.
    Am Heart J. 2011;162:425-35.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
26. RODRIGUEZ F , Joynt KE, Lopez L, Saldana F, et al
    Readmission rates for Hispanic Medicare beneficiaries with heart failure and acute myocardial infarction.
    Am Heart J. 2011;162:254-261.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. PFISTER R , Sharp SJ, Luben R, Wareham NJ, et al
    Plasma vitamin C predicts incident heart failure in men and women in European Prospective Investigation into Cancer and Nutrition-Norfolk prospective study.
    Am Heart J. 2011;162:246-53.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
28. MITCHELL JE , Tam SW, Trivedi K, Taylor AL, et al
    Atrial fibrillation and mortality in African American patients with heart failure: Results from the African American Heart Failure Trial (A-HeFT).
    Am Heart J. 2011;162:154-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. CHIONCEL O , Vinereanu D, Datcu M, Ionescu DD, et al
    The Romanian Acute Heart Failure Syndromes (RO-AHFS) Registry.
    Am Heart J. 2011;162:142-153.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. NOROZI K , Buchhorn R, Yasin A, Geyer S, et al
    Growth differentiation factor 15: An additional diagnostic tool for the risk stratification of developing heart failure in patients with operated congenital heart defects?
    Am Heart J. 2011;162:131-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. FRENCH JK , Armstrong PW, Cohen E, Kleiman NS, et al
    Cardiogenic shock and heart failure post-percutaneous coronary intervention in ST-elevation myocardial infarction: Observations from "Assessment of Pexelizumab in Acute Myocardial Infarction".
    Am Heart J. 2011;162:89-97.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. SHAH SJ , Fonarow GC, Gheorghiade M, Lang RM, et al
    Phase II trials in heart failure: The role of cardiovascular imaging.
    Am Heart J. 2011;162:3-15.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. VENTURA HO , Gaddam KK
    Geographic variations of acute heart failure syndromes The importance of clinical registries.
    Am Heart J. 2011;162:1-2.
    PubMed     Text format     Related articles   
    
    
    
    June 2011
34. VERMA A , Pfeffer MA, Skali H, Rouleau J, et al
    Incremental value of echocardiographic assessment beyond clinical evaluation for prediction of death and development of heart failure after high-risk myocardial infarction.
    Am Heart J. 2011;161:1156-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. DINI FL , Capozza P, Donati F, Simioniuc A, et al
    Patterns of left ventricular remodeling in chronic heart failure: Prevalence and prognostic implications.
    Am Heart J. 2011;161:1088-95.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. PERIN EC , Silva GV, Henry TD, Cabreira-Hansen MG, et al
    A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF).
    Am Heart J. 2011;161:1078-1087.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. PANG PS , Gheorghiade M, Dihu J, Swedberg K, et al
    Effects of tolvaptan on physician-assessed symptoms and signs in patients hospitalized with acute heart failure syndromes: Analysis from the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) Trials.
    Am Heart J. 2011;161:1067-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. VAN BOMMEL RJ , Ypenburg C, Mollema SA, Borleffs CJ, et al
    Site of latest activation in patients eligible for cardiac resynchronization therapy: Patterns of dyssynchrony among different QRS configurations and impact of heart failure etiology.
    Am Heart J. 2011;161:1060-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. JOHANSSON P , Lesman-Leegte I, Svensson E, Voors A, et al
    Depressive symptoms and inflammation in patients hospitalized for heart failure.
    Am Heart J. 2011;161:1053-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. ATCHLEY AE , Iskandrian AE, Bensimhon D, Ellis SJ, et al
    Relationship of technetium-99m tetrofosmin-gated rest single-photon emission computed tomography myocardial perfusion imaging to death and hospitalization in heart failure patients: results from the nuclear ancillary study of the HF-ACTION trial.
    Am Heart J. 2011;161:1038-45.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. AARONES M , Gullestad L, Aakhus S, Ueland T, et al
    Prognostic value of cardiac troponin T in patients with moderate to severe heart failure scheduled for cardiac resynchronization therapy.
    Am Heart J. 2011;161:1031-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. FONAROW GC , Yancy CW, Hernandez AF, Peterson ED, et al
    Potential impact of optimal implementation of evidence-based heart failure therapies on mortality.
    Am Heart J. 2011;161:1024-1030.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. PANG PS , Mehra M, Maggioni AP, Filippatos G, et al
    Rationale, design, and results from RENO-DEFEND 1: A randomized, dose-finding study of the selective A1 adenosine antagonist SLV320 in patients hospitalized with acute heart failure.
    Am Heart J. 2011;161:1012-1023.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. STEVENSON LW
    Projecting heart failure into bankruptcy in 2012?
    Am Heart J. 2011;161:1007-11.
    PubMed     Text format     Related articles   
    
    
    
    
45. DHILLON OS , Narayan HK, Quinn PA, Squire IB, et al
    Interleukin 33 and ST2 in non-ST-elevation myocardial infarction: Comparison with Global Registry of Acute Coronary Events Risk Scoring and NT-proBNP.
    Am Heart J. 2011;161:1163-70.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. WILSON SR , Sabatine MS, Wiviott SD, Ray KK, et al
    Assessment of adiponectin and the risk of recurrent cardiovascular events in patients presenting with an acute coronary syndrome: Observations from the Pravastatin Or atorVastatin Evaluation and Infection Trial-Thrombolysis in Myocardial Infarction 22
    Am Heart J. 2011;161:1147-1155.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
47. ZULUAGA MC , Guallar-Castillon P, Conthe P, Rodriguez-Pascual C, et al
    Housing conditions and mortality in older patients hospitalized for heart failure.
    Am Heart J. 2011;161:950-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. TESTANI JM , Cappola TP, McCauley BD, Chen J, et al
    Impact of worsening renal function during the treatment of decompensated heart failure on changes in renal function during subsequent hospitalization.
    Am Heart J. 2011;161:944-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. OCARANZA MP , Gabrielli L, Mora I, Garcia L, et al
    Markedly increased Rho-kinase activity in circulating leukocytes in patients with chronic heart failure.
    Am Heart J. 2011;161:931-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. GUPTA S , Rohatgi A, Ayers CR, Patel PC, et al
    Risk scores versus natriuretic peptides for identifying prevalent stage B heart failure.
    Am Heart J. 2011;161:923-930.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. EAPEN ZJ , Reed SD, Curtis LH, Hernandez AF, et al
    Do heart failure disease management programs make financial sense under a bundled payment system?
    Am Heart J. 2011;161:916-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. MOERTL D , Hammer A, Steiner S, Hutuleac R, et al
    Dose-dependent effects of omega-3-polyunsaturated fatty acids on systolic left ventricular function, endothelial function, and markers of inflammation in chronic heart failure of nonischemic origin A double-blind, placebo-controlled, 3-arm study.
    Am Heart J. 2011;161:915.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. KOTECHA D , Ngo K, Walters JA, Manzano L, et al
    Erythropoietin as a treatment of anemia in heart failure: Systematic review of randomized trials.
    Am Heart J. 2011;161:822-831.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
54. THOMAS KL , Hernandez AF, Dai D, Heidenreich P, et al
    Association of race/ethnicity with clinical risk factors, quality of care, and acute outcomes in patients hospitalized with heart failure.
    Am Heart J. 2011;161:746-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. EDELMANN F , Stahrenberg R, Polzin F, Kockskamper A, et al
    Impaired physical quality of life in patients with diastolic dysfunction associates more strongly with neurohumoral activation than with echocardiographic parameters Quality of life in diastolic dysfunction.
    Am Heart J. 2011;161:797-804.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. LIN GM , Li YH, Chu KM, Han CL, et al
    Prevalence and characteristics of patients with clinical improvement but not significant left ventricular reverse remodeling after cardiac resynchronization therapy.
    Am Heart J. 2011;161:e21.
    PubMed     Text format     Related articles   
    
    
    
    March 2011
57. ATHER S , Chan W, Chillar A, Aguilar D, et al
    Association of systolic blood pressure with mortality in patients with heart failure with reduced ejection fraction: A complex relationship.
    Am Heart J. 2011;161:567-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. ABRAHAM WT , Adamson PB, Hasan A, Bourge RC, et al
    Safety and accuracy of a wireless pulmonary artery pressure monitoring system in patients with heart failure.
    Am Heart J. 2011;161:558-66.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. TRACHTENBERG B , Velazquez DL, Williams AR, McNiece I, et al
    Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double-b
    Am Heart J. 2011;161:487-93.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. FIACCADORI E , Regolisti G, Maggiore U, Parenti E, et al
    Ultrafiltration in heart failure.
    Am Heart J. 2011;161:439-49.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. ABDEL-QADIR HM , Tu JV, Newton GE, Austin PC, et al
    Dynamic furosemide dose: A marker of adverse heart failure outcomes.
    Am Heart J. 2011;161:e15.
    PubMed     Text format     Related articles   
    
    
    
    
62. PARRINELLO G , Torres D, Paterna S, Licata G, et al
    Time to ferry heart failure onto new shores: The need to effectively customize long-term therapy.
    Am Heart J. 2011;161:e13-4.
    PubMed     Text format     Related articles   
    
    
    
    
63. SHANKS M , Delgado V, Ng AC, Auger D, et al
    Clinical and echocardiographic predictors of nonresponse to cardiac resynchronization therapy.
    Am Heart J. 2011;161:552-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
64. FINZI AA , Latini R, Barlera S, Rossi MG, et al
    Effects of n-3 polyunsaturated fatty acids on malignant ventricular arrhythmias in patients with chronic heart failure and implantable cardioverter-defibrillators: A substudy of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza
    Am Heart J. 2011;161:338-343.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. KADISH A , Nademanee K, Volosin K, Krueger S, et al
    A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure.
    Am Heart J. 2011;161:329-337.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. TEBBE U , Schellong SM, Haas S, Gerlach HE, et al
    Certoparin versus unfractionated heparin to prevent venous thromboembolic events in patients hospitalized because of heart failure: A subgroup analysis of the randomized, controlled CERTIFY study.
    Am Heart J. 2011;161:322-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. GHEORGHIADE M , Pang PS, O'Connor CM, Prasad K, et al
    Clinical development of pharmacologic agents for acute heart failure syndromes: A proposal for a mechanistic translational phase.
    Am Heart J. 2011;161:224-32.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. SCHRIER RW , Gheorghiade M
    Challenge of rehospitalizations for heart failure: Potential of natriuretic doses of mineralocorticoid receptor antagonists.
    Am Heart J. 2011;161:221-3.
    PubMed     Text format     Related articles   
    
    
    
    January 2011
69. ALSHEIKH-ALI AA , Trikalinos TA, Ruthazer R, Terrin N, et al
    Risk of arrhythmic and nonarrhythmic death in patients with heart failure and chronic kidney disease.
    Am Heart J. 2011;161:204-209.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. GASTELURRUTIA P , Pascual-Figal D, Vazquez R, Cygankiewicz I, et al
    Obesity paradox and risk of sudden death in heart failure Results from the MUerte Subita en Insuficiencia Cardiaca (MUSIC) Study.
    Am Heart J. 2011;161:158-64.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
71. HAMAGUCHI S , Kinugawa S, Tsuchihashi-Makaya M, Goto K, et al
    Spironolactone use at discharge was associated with improved survival in hospitalized patients with systolic heart failure.
    Am Heart J. 2010;160:1156-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. UTHAMALINGAM S , Kandala J, Daley M, Patvardhan E, et al
    Serum albumin and mortality in acutely decompensated heart failure.
    Am Heart J. 2010;160:1149-55.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. ADAMS KF JR , Mehra MR, Oren RM, O'Connor CM, et al
    Prospective evaluation of the association between cardiac troponin T and markers of disturbed erythropoiesis in patients with heart failure.
    Am Heart J. 2010;160:1142-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. BHAKTA D , Groh MR, Shen C, Pascuzzi RM, et al
    Increased mortality with left ventricular systolic dysfunction and heart failure in adults with myotonic dystrophy type 1.
    Am Heart J. 2010;160:1137-1141.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. POGGIO R , Arazi HC, Giorgi M, Miriuka SG, et al
    Prediction of severe cardiovascular events by VE/Vco(2) slope versus peak Vo(2) in systolic heart failure: A meta-analysis of the published literature.
    Am Heart J. 2010;160:1004-14.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. ARQUES S
    Hypoalbuminemia as a risk factor of incident heart failure in the elderly.
    Am Heart J. 2010;160:e39.
    PubMed     Text format     Related articles   
    
    
    
    
77. SAIA F , Grigioni F, Marzocchi A, Branzi A, et al
    Management of acute left ventricular dysfunction after primary percutaneous coronary intervention for ST elevation acute myocardial infarction.
    Am Heart J. 2010;160.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
78. PARODI G , Antoniucci D
    Left ventricular remodeling after primary percutaneous coronary intervention.
    Am Heart J. 2010;160.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. BOLOGNESE L
    Changing patterns of ST elevation myocardial infarction epidemiology.
    Am Heart J. 2010;160.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
80. WU AH , Ghali JK, Neuberg GW, O'Connor CM, et al
    Uric acid level and allopurinol use as risk markers of mortality and morbidity in systolic heart failure.
    Am Heart J. 2010;160:928-33.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. CHASE P , Arena R, Guazzi M, Myers J, et al
    Prognostic usefulness of the functional aerobic reserve in patients with heart failure.
    Am Heart J. 2010;160:922-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
82. YAMAJI M , Tsutamoto T, Kawahara C, Nishiyama K, et al
    Effect of eplerenone versus spironolactone on cortisol and hemoglobin A(1c) levels in patients with chronic heart failure.
    Am Heart J. 2010;160:915-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
83. GUAZZI M , Myers J, Vicenzi M, Bensimhon D, et al
    Cardiopulmonary exercise testing characteristics in heart failure patients with and without concomitant chronic obstructive pulmonary disease.
    Am Heart J. 2010;160:900-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
84. BOXER RS , Kenny AM, Cheruvu VK, Vest M, et al
    Serum 25-hydroxyvitamin D concentration is associated with functional capacity in older adults with heart failure.
    Am Heart J. 2010;160:893-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
85. KOCIOL RD , Hammill BG, Fonarow GC, Klaskala W, et al
    Generalizability and longitudinal outcomes of a national heart failure clinical registry: Comparison of Acute Decompensated Heart Failure National Registry (ADHERE) and non-ADHERE Medicare beneficiaries.
    Am Heart J. 2010;160:885-92.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
86. CIAMPI Q , Pratali L, Citro R, Villari B, et al
    Clinical and prognostic role of pressure-volume relationship in the identification of responders to cardiac resynchronization therapy.
    Am Heart J. 2010;160:906-14.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
87. RUSCONI PG , Ludwig DA, Ratnasamy C, Mas R, et al
    Serial measurements of serum NT-proBNP as markers of left ventricular systolic function and remodeling in children with heart failure.
    Am Heart J. 2010;160:776-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
88. CARSON P , Fiuzat M, O'Connor C, Anand I, et al
    Determination of hospitalization type by investigator case report form or adjudication committee in a large heart failure clinical trial (beta-Blocker Evaluation of Survival Trial [BEST]).
    Am Heart J. 2010;160:649-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
89. GHALI JK
    Do heart failure trials need an end point committee?
    Am Heart J. 2010;160:571-3.
    PubMed     Text format     Related articles   
    
    
    
    
90. AUGER D , van Bommel RJ, Bertini M, Delgado V, et al
    Prevalence and characteristics of patients with clinical improvement but not significant left ventricular reverse remodeling after cardiac resynchronization therapy.
    Am Heart J. 2010;160:737-43.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
91. YAN RT , Fernandes V, Yan AT, Cushman M, et al
    Fibrinogen and left ventricular myocardial systolic function: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Am Heart J. 2010;160:479-86.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
92. ZHANG Y , Safar ME, Iaria P, Agnoletti D, et al
    Prevalence and prognosis of left ventricular diastolic dysfunction in the elderly: The PROTEGER Study.
    Am Heart J. 2010;160:471-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
93. DANESHVAR D , Wei J, Tolstrup K, Thomson LE, et al
    Diastolic dysfunction: Improved understanding using emerging imaging techniques.
    Am Heart J. 2010;160:394-404.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
94. MUZZARELLI S , Leibundgut G, Maeder MT, Rickli H, et al
    Predictors of early readmission or death in elderly patients with heart failure.
    Am Heart J. 2010;160:308-314.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
95. ROYSLAND R , Masson S, Omland T, Milani V, et al
    Prognostic value of osteoprotegerin in chronic heart failure: The GISSI-HF trial.
    Am Heart J. 2010;160:286-293.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
96. GOPAL DM , Kalogeropoulos AP, Georgiopoulou VV, Tang WW, et al
    Serum albumin concentration and heart failure risk The Health, Aging, and Body Composition Study.
    Am Heart J. 2010;160:279-285.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
97. ABDEL-QADIR HM , Tu JV, Yun L, Austin PC, et al
    Diuretic dose and long-term outcomes in elderly patients with heart failure after hospitalization.
    Am Heart J. 2010;160:264-271.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
98. WEST RL , Hernandez AF, O'Connor CM, Starling RC, et al
    A review of dyspnea in acute heart failure syndromes.
    Am Heart J. 2010;160:209-214.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
99. DONOHUE JM , Zhang Y, Lave JR, Gellad WF, et al
    The Medicare drug benefit (Part D) and treatment of heart failure in older adults.
    Am Heart J. 2010;160:159-65.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
100. SHAMSHAD F , Kenchaiah S, Finn PV, Soler-Soler J, et al
     Fatal myocardial rupture after acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALsartan In Acute myocardial iNfarcTion Trial (VALIANT).
     Am Heart J. 2010;160:145-51.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
101. SETOGUCHI S , Glynn RJ, Stedman M, Flavell CM, et al
     Hospice, opiates, and acute care service use among the elderly before death from heart failure or cancer.
     Am Heart J. 2010;160:139-44.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
102. PATEL UD , Greiner MA, Fonarow GC, Phatak H, et al
     Associations between worsening renal function and 30-day outcomes among Medicare beneficiaries hospitalized with heart failure.
     Am Heart J. 2010;160:132-138.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
103. SANDERS GD , Kong MH, Al-Khatib SM, Peterson ED, et al
     Cost-effectiveness of implantable cardioverter defibrillators in patients >or=65 years of age.
     Am Heart J. 2010;160:122-31.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     June 2010
104. AGOSTONI P , Apostolo A, Cattadori G, Salvioni E, et al
     Effects of beta-blockers on ventilation efficiency in heart failure.
     Am Heart J. 2010;159:1067-73.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
105. BORIANI G , Kranig W, Donal E, Calo L, et al
     A randomized double-blind comparison of biventricular versus left ventricular stimulation for cardiac resynchronization therapy: the Biventricular versus Left Univentricular Pacing with ICD Back-up in Heart Failure Patients (B-LEFT HF) trial.
     Am Heart J. 2010;159:1052-1058.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
106. SATO N , Kajimoto K, Asai K, Mizuno M, et al
     Acute decompensated heart failure syndromes (ATTEND) registry. A prospective observational multicenter cohort study: rationale, design, and preliminary data.
     Am Heart J. 2010;159:949-955.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
107. KAPOOR JR , Heidenreich PA
     Reply to the letter to the editor for "Obesity and survival in patients with heart failure and preserved systolic function: A U-shaped relationship".
     Am Heart J. 2010;159:e33.
     PubMed     Text format     Related articles   
     
     
     
     
108. LU C , Chen S, Chen YC
     "Obesity and survival in patients with heart failure and preserved systolic function: a U-shaped relationship (Am Heart J 2010;159:75-80).
     Am Heart J. 2010;159:e31.
     PubMed     Text format     Related articles   
     
     
     
     
109. ABRAHAM WT , Gras D, Yu CM, Guzzo L, et al
     Rationale and design of a randomized clinical trial to assess the safety and efficacy of frequent optimization of cardiac resynchronization therapy: the Frequent Optimization Study Using the QuickOpt Method (FREEDOM) trial.
     Am Heart J. 2010;159:944-948.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     May 2010
110. O'CONNOR CM , Miller AB, Blair JE, Konstam MA, et al
     Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: Results from efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan (EVEREST) program
     Am Heart J. 2010;159:841-849.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
111. GUPTA S , Berry JD, Ayers CR, Matulevicius SA, et al
     Association of Health Aging and Body Composition (ABC) Heart Failure score with cardiac structural and functional abnormalities in young individuals.
     Am Heart J. 2010;159:817-24.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
112. HERDA LR , Trimpert C, Nauke U, Landsberger M, et al
     Effects of immunoadsorption and subsequent immunoglobulin G substitution on cardiopulmonary exercise capacity in patients with dilated cardiomyopathy.
     Am Heart J. 2010;159:809-16.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     April 2010
113. MARIJON E , Trinquart L, Otmani A, Leclercq C, et al
     Predictors for short-term progressive heart failure death in New York Heart Association II patients implanted with a cardioverter defibrillator--the EVADEF study.
     Am Heart J. 2010;159:659-664.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
114. WALSH MN , Yancy CW, Albert NM, Curtis AB, et al
     Electronic health records and quality of care for heart failure.
     Am Heart J. 2010;159:635-642.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
115. BHARDWAJ A , Rehman SU, Mohammed A, Baggish AL, et al
     Design and methods of the Pro-B Type Natriuretic Peptide Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study.
     Am Heart J. 2010;159:532-538.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
116. KAZORY A
     Need for a unified decision-making tool for ultrafiltration therapy in heart failure; call for action.
     Am Heart J. 2010;159:505-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     March 2010
117. HERNANDEZ AF , Hammill BG, Peterson ED, Yancy CW, et al
     Relationships between emerging measures of heart failure processes of care and clinical outcomes.
     Am Heart J. 2010;159:406-413.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
118. LAPOINTE NM , Sun JL, Kaplan S
     In-hospital management of patients with atrial flutter.
     Am Heart J. 2010;159:370-376.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
119. YI F , Yu J, Liu B
     Effect of interval (V-V) optimization in ischemic versus nonischemic patients after cardiac resynchronization therapy.
     Am Heart J. 2010;159:e11.
     PubMed     Text format     Related articles   
     
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: